Dr. Thomas Goedecke, Senior Pharmacovigilance Specialist, Pharmacovigilance Office, Quality and Safety of Medicines, European Medicines Agency (EMA).
Since joining EMA in 2006, Thomas Goedecke worked in major areas of pharmacovigilance, including data collection and management in EudraVigilance, signal detection and risk management for centrally authorised medicines, including medication errors. Since 2015 he leads on the implementation of the PRAC strategy for measuring impact of pharmacovigilance activities and coordinates the commissioning of impact research and risk minimisation effectiveness studies for the EU medicines regulatory network. He authored regulatory and scientific guidance for stakeholders in the area of impact research methodologies with contributions to the ENCePP Methods Guide and relevant good pharmacovigilance practice (GVP) guidelines. Other responsibilities include the good practice guide on medication error reporting and risk minimisation and prevention, as well as signal detection activities.